SPH4336

· Shanghai Pharmaceuticals Holding Co., Ltd

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for SPH4336, covering 2024-06-17 to 2026-01-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer [Phase 2, Phase 3]

See pricing